Ethical issues raised by new genomic technologies: the case study of newborn genome screening
Cambridge Prisms: Precision Medicine · 2022
DOI: 10.1017/pcm.2022.2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, 2022. Verfasst von Rachel Horton und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Personalised Medicine, St Anne's College, University of Oxford, Oxford, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Personalised Medicine, St Anne's College, University of Oxford, Oxford, UK.
- Clinical Ethics, Law and Society group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
- Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
- NIHR Southampton Biomedical Research Centre, Southampton General Hospital, Southampton, UK.
ORCID-Profile: Rachel Horton, Anneke Lucassen
Förderung
- Wellcome Trust
Zitieren
APA
Horton, R., & Lucassen, A. (2022). Ethical issues raised by new genomic technologies: the case study of newborn genome screening. Cambridge Prisms: Precision Medicine. https://doi.org/10.1017/pcm.2022.2
Vancouver
Horton R, Lucassen A. Ethical issues raised by new genomic technologies: the case study of newborn genome screening. Cambridge Prisms: Precision Medicine. 2022. doi:10.1017/pcm.2022.2
BibTeX
@article{Horton2022,
author = {Horton, Rachel and Lucassen, Anneke},
title = {Ethical issues raised by new genomic technologies: the case study of newborn genome screening},
journal = {Cambridge Prisms: Precision Medicine},
year = {2022},
doi = {10.1017/pcm.2022.2}
}
EUVIMED